| A | B | C | D | E | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Resource | WG | FMG Recommendation | Track (N=Normative AR=Additional Resources) Green = WG Finalized | WG → FMG | Notes | Target (if AR Track) | ||||||||||||||||||
2 | AdministrableProductDefinition | brr | AR Group 2 | N | x | ||||||||||||||||||||
3 | ClinicalUseDefinition | brr | AR Group 2 | N | x | ||||||||||||||||||||
4 | Ingredient | brr | AR Group 2 | N | x | ||||||||||||||||||||
5 | ManufacturedItemDefinition | brr | AR Group 2 | N | x | ||||||||||||||||||||
6 | MedicinalProductDefinition | brr | AR Group 2 | N | x | ||||||||||||||||||||
7 | PackagedProductDefinition | brr | AR Group 2 | N | x | ||||||||||||||||||||
8 | RegulatedAuthorization | brr | AR Group 2 | N | x | ||||||||||||||||||||
9 | ResearchStudy | brr | | N | x | 2025-10-21: BRR Voted to keep ResearchStudy in normative track. | |||||||||||||||||||
10 | ResearchSubject | brr | | N | x | 2025-10-21: BRR Voted to keep ResearchSubject in normative track | |||||||||||||||||||
11 | Substance | brr | | N | x | ||||||||||||||||||||
12 | SubstanceDefinition | brr | AR Group 2 | N | x | ||||||||||||||||||||
13 | SubstanceNucleicAcid | brr | AR Group 2 | x | |||||||||||||||||||||
14 | SubstancePolymer | brr | AR Group 2 | x | |||||||||||||||||||||
15 | SubstanceProtein | brr | AR Group 2 | x | |||||||||||||||||||||
16 | SubstanceReferenceInformation | brr | AR Group 2 | x | |||||||||||||||||||||
17 | SubstanceSourceMaterial | brr | | x | |||||||||||||||||||||
18 | Consent | cbcc | | N | x | ||||||||||||||||||||
19 | ActivityDefinition | cds | | N | x | Citation should be AR, all others Normative | |||||||||||||||||||
20 | ArtifactAssessment | cds | AR Group 2 | N | x | Citation should be AR, all others Normative | |||||||||||||||||||
21 | Citation | cds | AR Group 2 | AR | x | Citation should be AR, all others Normative | EBM-on-FHIR IG | ||||||||||||||||||
22 | DetectedIssue | cds | | N | x | Citation should be AR, all others Normative | |||||||||||||||||||
23 | EventDefinition | cds | | N | x | Citation should be AR, all others Normative | |||||||||||||||||||
24 | Evidence | cds | AR Group 2 | N | x | Citation should be AR, all others Normative | |||||||||||||||||||
25 | EvidenceVariable | cds | AR Group 2 | N | x | Citation should be AR, all others Normative | |||||||||||||||||||
26 | GuidanceResponse | cds | | N | x | Citation should be AR, all others Normative | |||||||||||||||||||
27 | Library | cds | | N | x | Citation should be AR, all others Normative | |||||||||||||||||||
28 | PlanDefinition | cds | | N | x | Citation should be AR, all others Normative | |||||||||||||||||||
29 | RequestOrchestration | cds | | N | x | Citation should be AR, all others Normative | |||||||||||||||||||
30 | RiskAssessment | cds | | N | x | Citation should be AR, all others Normative | |||||||||||||||||||
31 | GenomicStudy | cg | AR Group 2 | AR | x | ||||||||||||||||||||
32 | MolecularDefinition | cg | AR Group 2 | AR | x | ||||||||||||||||||||
33 | MolecularSequence | cg | AR Group 2 | AR | x | ||||||||||||||||||||
34 | Measure | cqi | | N | x | Agreement on keeping Measure and MeasureReport | |||||||||||||||||||
35 | MeasureReport | cqi | | N | x | Agreement on keeping Measure and MeasureReport | |||||||||||||||||||
36 | DeviceAlert | dev | AR Group 2 | N | x | 2025-10-01: Confirmed by Devices WG (https://confluence.hl7.org/spaces/HCD/pages/358898432/2025-10-01+Devices+Main+Call+Agenda+and+Minutes) | |||||||||||||||||||
37 | DeviceMetric | dev | N | N | x | 2025-10-01: Confirmed by Devices WG (https://confluence.hl7.org/spaces/HCD/pages/358898432/2025-10-01+Devices+Main+Call+Agenda+and+Minutes) | |||||||||||||||||||
38 | ActorDefinition | fhir | | N | x | ||||||||||||||||||||
39 | Basic | fhir | | N | x | ||||||||||||||||||||
40 | Binary | fhir | | N | x | ||||||||||||||||||||
41 | Bundle | fhir | | N | x | ||||||||||||||||||||
42 | CapabilityStatement | fhir | | N | x | ||||||||||||||||||||
43 | CompartmentDefinition | fhir | | N | x | ||||||||||||||||||||
44 | ExampleScenario | fhir | | N | x | ||||||||||||||||||||
45 | GraphDefinition | fhir | | AR | x | NOTE: This resource is referenced in Formulary IG, but optional usage Clinical Guidelines makes pretty extensive use of this resource to describe definitions of documents | |||||||||||||||||||
46 | Group | fhir | | N | x | ||||||||||||||||||||
47 | ImplementationGuide | fhir | | N | x | ||||||||||||||||||||
48 | List | fhir | | N | x | ||||||||||||||||||||
49 | OperationDefinition | fhir | | N | x | ||||||||||||||||||||
50 | OperationOutcome | fhir | | N | x | ||||||||||||||||||||
51 | Parameters | fhir | | N | x | ||||||||||||||||||||
52 | Questionnaire | fhir | | N | x | ||||||||||||||||||||
53 | QuestionnaireResponse | fhir | | N | x | ||||||||||||||||||||
54 | Requirements | fhir | | N | x | ||||||||||||||||||||
55 | SearchParameter | fhir | | N | x | ||||||||||||||||||||
56 | StructureDefinition | fhir | | N | x | ||||||||||||||||||||
57 | StructureMap | fhir | | N | x | ||||||||||||||||||||
58 | Subscription | fhir | | N | x | ||||||||||||||||||||
59 | SubscriptionStatus | fhir | | N | x | ||||||||||||||||||||
60 | SubscriptionTopic | fhir | | N | x | ||||||||||||||||||||
61 | TestPlan | fhir | AR Group 2 | AR | x | ||||||||||||||||||||
62 | TestReport | fhir | AR Group 2 | AR | x | ||||||||||||||||||||
63 | TestScript | fhir | | AR | x | ||||||||||||||||||||
64 | Claim | fm | | N | x | ||||||||||||||||||||
65 | ClaimResponse | fm | | N | x | ||||||||||||||||||||
66 | Contract | fm | | AR | x | ||||||||||||||||||||
67 | Coverage | fm | | N | x | ||||||||||||||||||||
68 | CoverageEligibilityRequest | fm | | N | x | ||||||||||||||||||||
69 | CoverageEligibilityResponse | fm | | N | x | ||||||||||||||||||||
70 | EnrollmentRequest | fm | AR Group 2 | AR | x | ||||||||||||||||||||
71 | EnrollmentResponse | fm | AR Group 2 | AR | x | ||||||||||||||||||||
72 | ExplanationOfBenefit | fm | | N | x | ||||||||||||||||||||
73 | Invoice | fm | | Further consultation needed | x | ||||||||||||||||||||
74 | PaymentNotice | fm | | N | x | ||||||||||||||||||||
75 | PaymentReconciliation | fm | | N | x | ||||||||||||||||||||
76 | ImagingSelection | ii | AR Group 2 | N | x | IHE Radiology, FHIRCast, prefer to keep unless there are significant changes coming 2025-09-30: Imaging Integration reviewed the spreadsheet and can confirm that the resources we manage are in the correct track — both ImagingStudy and ImagingSelection to go normative in R6. | |||||||||||||||||||
77 | ImagingStudy | ii | | N | x | 2025-09-30: Imaging Integration reviewed the spreadsheet and can confirm that the resources we manage are in the correct track — both ImagingStudy and ImagingSelection to go normative in R6. | |||||||||||||||||||
78 | MessageDefinition | inm | | N | x | 2025-09-30: InM voted this morning to keep MessageHeader and MessageDefinition in base FHIR for R6, such that they will go normative. We found the reference to the IGs that profile MessageDefinition useful in this decision. | |||||||||||||||||||
79 | MessageHeader | inm | | N | x | 2025-09-30: InM voted this morning to keep MessageHeader and MessageDefinition in base FHIR for R6, such that they will go normative. We found the reference to the IGs that profile MessageDefinition useful in this decision. | |||||||||||||||||||
80 | BiologicallyDerivedProduct | oo | | N | x | ||||||||||||||||||||
81 | BiologicallyDerivedProductDispense | oo | AR Group 1 | AR | x | Preliminary, OO need to discuss more | |||||||||||||||||||
82 | BodyStructure | oo | | N | x | ||||||||||||||||||||
83 | Device | oo | | N | x | ||||||||||||||||||||
84 | DeviceAssociation | oo | AR Group 1 | N | x | DEV is in support of N, they wish it were stable - key piece for them, important connection. | |||||||||||||||||||
85 | DeviceDefinition | oo | | N | x | ||||||||||||||||||||
86 | DeviceDispense | oo | AR Group 1 | AR | x | ||||||||||||||||||||
87 | DeviceRequest | oo | | N | x | ||||||||||||||||||||
88 | DeviceUsage | oo | AR Group 1 | AR | x | ||||||||||||||||||||
89 | DiagnosticReport | oo | | N | x | ||||||||||||||||||||
90 | DocumentReference | oo | | N | x | ||||||||||||||||||||
91 | InventoryItem | oo | AR Group 1 | AR | x | ||||||||||||||||||||
92 | InventoryReport | oo | AR Group 1 | AR | x | ||||||||||||||||||||
93 | NutritionIntake | oo | | N | x | ||||||||||||||||||||
94 | NutritionOrder | oo | | N | x | ||||||||||||||||||||
95 | NutritionProduct | oo | | N | x | ||||||||||||||||||||
96 | Observation | oo | | N | x | $operation stats will go AR, $lastn will stay | |||||||||||||||||||
97 | ObservationDefinition | oo | | N | x | ||||||||||||||||||||
98 | ServiceRequest | oo | | N | x | ||||||||||||||||||||
99 | Specimen | oo | | N | x | ||||||||||||||||||||
100 | SpecimenDefinition | oo | | N | x |